Yuki Hirose

2.4k total citations
123 papers, 1.3k citations indexed

About

Yuki Hirose is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yuki Hirose has authored 123 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 47 papers in Surgery and 40 papers in Oncology. Recurrent topics in Yuki Hirose's work include Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Gallbladder and Bile Duct Disorders (16 papers). Yuki Hirose is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Gallbladder and Bile Duct Disorders (16 papers). Yuki Hirose collaborates with scholars based in Japan, United States and India. Yuki Hirose's co-authors include S Ohara, Toshifumi Wakai, Ono T, N Ogawa, Yasuo Watanabe, Masayuki Nagahashi, Takashi Kobayashi, Kazuaki Takabe, Kizuki Yuza and Kohei Miura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Yuki Hirose

105 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Hirose Japan 18 469 372 297 240 238 123 1.3k
Ju‐Yeon Kim South Korea 20 420 0.9× 279 0.8× 267 0.9× 174 0.7× 273 1.1× 64 1.3k
Jiang Wu China 24 405 0.9× 464 1.2× 282 0.9× 224 0.9× 118 0.5× 101 1.9k
Naoko Udaka Japan 16 546 1.2× 228 0.6× 201 0.7× 302 1.3× 70 0.3× 39 1.1k
Jing‐Ping Lin United States 21 788 1.7× 303 0.8× 211 0.7× 327 1.4× 137 0.6× 52 2.1k
Noriko Makita Japan 22 671 1.4× 376 1.0× 239 0.8× 209 0.9× 51 0.2× 75 1.7k
Irina Mikolaenko United States 12 786 1.7× 280 0.8× 103 0.3× 122 0.5× 199 0.8× 27 1.4k
Ewa Matyja Poland 24 614 1.3× 135 0.4× 284 1.0× 184 0.8× 414 1.7× 127 1.9k
Leonie Jestaedt Germany 13 725 1.5× 270 0.7× 140 0.5× 233 1.0× 269 1.1× 16 2.1k
Alexandra Kretz Germany 18 708 1.5× 135 0.4× 137 0.5× 158 0.7× 79 0.3× 34 1.4k
Mineyoshi Aoyama Japan 22 676 1.4× 274 0.7× 64 0.2× 116 0.5× 133 0.6× 74 1.4k

Countries citing papers authored by Yuki Hirose

Since Specialization
Citations

This map shows the geographic impact of Yuki Hirose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Hirose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Hirose more than expected).

Fields of papers citing papers by Yuki Hirose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Hirose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Hirose. The network helps show where Yuki Hirose may publish in the future.

Co-authorship network of co-authors of Yuki Hirose

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Hirose. A scholar is included among the top collaborators of Yuki Hirose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Hirose. Yuki Hirose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hirose, Yuki, Atsushi Oba, Aya Maekawa, et al.. (2025). Arterial resection and divestment in pancreatic cancer surgery in the era of multidisciplinary treatment: decadal comparative study. BJS Open. 9(2). 2 indexed citations
3.
Kano, Yosuke, Hiroshi Ichikawa, Yusuke Muneoka, et al.. (2024). [Thoracic Aortic Thrombosis during Preoperative 5-Fluorouracil plus Cisplatin Therapy for Esophageal Cancer].. PubMed. 51(13). 1428–1430.
4.
Ichikawa, Hiroshi, Masaki Aizawa, Yusuke Muneoka, et al.. (2024). Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer. BMC Cancer. 24(1). 719–719. 1 indexed citations
5.
Maekawa, Aya, Atsushi Oba, Yosuke Inoue, et al.. (2024). A proposal of ABCD metastasectomy criteria for synchronous/metachronous metastatic pancreatic cancer in the era of multidisciplinary treatment. British journal of surgery. 111(1). 8 indexed citations
6.
Ichikawa, Hiroshi, Masaki Aizawa, Yosuke Kano, et al.. (2024). Landscape of homologous recombination deficiency in gastric cancer and clinical implications for first-line chemotherapy. Gastric Cancer. 27(6). 1273–1286. 6 indexed citations
8.
Hanyu, Takaaki, Hiroshi Ichikawa, Yosuke Kano, et al.. (2024). Risk factors for death from other diseases after curative gastrectomy and lymph node dissection for gastric cancer. BMC Surgery. 24(1). 16–16. 1 indexed citations
9.
Hirose, Yuki, et al.. (2024). VERTECS: development status of the mission payload specialized in visible EBL observation. 34–34. 2 indexed citations
12.
Hirose, Yuki, Yasunori Oda, Makoto Kimura, et al.. (2023). Reduction of claudin-5 and aquaporin-4 in the rat hippocampal CA-1 and CA-3 regions of a learned helplessness model of depression. Pharmacology Biochemistry and Behavior. 234. 173676–173676. 2 indexed citations
13.
Ichikawa, Hiroshi, Kazuyasu Takizawa, Masayuki Nagahashi, et al.. (2023). Clinical Significance of Phosphorylated Sphingosine Kinase 1 Expression in Pancreatic Ductal Adenocarcinoma. Anticancer Research. 43(9). 3969–3977. 4 indexed citations
14.
Sakata, Jun, Yuki Hirose, Tatsuya Nomura, et al.. (2023). Extent of regional lymphadenectomy and number-based nodal classification for non-ampullary duodenal adenocarcinoma. European Journal of Surgical Oncology. 49(12). 107122–107122. 1 indexed citations
15.
Irukayama‐Tomobe, Yoko, et al.. (2022). Effect of sevoflurane preconditioning on sleep reintegration after alteration by lipopolysaccharide. Journal of Sleep Research. 31(5). e13556–e13556. 1 indexed citations
16.
Hirose, Yuki, Manabu Abe, Kenji Sakimura, et al.. (2020). Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway. Proceedings of the National Academy of Sciences. 117(37). 23106–23112. 12 indexed citations
17.
Yuza, Kizuki, Masato Nakajima, Masayuki Nagahashi, et al.. (2018). Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression. Journal of Surgical Research. 232. 186–194. 33 indexed citations
18.
Sakata, Jun, Takashi Kobayashi, Yosuke Tajima, et al.. (2017). Relevance of Dissection of the Posterior Superior Pancreaticoduodenal Lymph Nodes in Gallbladder Carcinoma. Annals of Surgical Oncology. 24(9). 2474–2481. 15 indexed citations
19.
FUJII, Hidenori, et al.. (2017). Reduced-port surgery aided by the newly developed free jaw clip and free loop plus for local resection of gastric submucosal tumors. Annals of Laparoscopic and Endoscopic Surgery. 2(4). 51–51. 1 indexed citations
20.
Tabuchi, Keiji, et al.. (2013). A Case of Glomangiopericytoma of the Nasal Cavity. Practica Oto-Rhino-Laryngologica. 106(8). 705–710.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026